Literature DB >> 29602154

The association of IL-33 and Foxp3 gene polymorphisms with recurrent pregnancy loss in Egyptian women.

Haidy E Zidan1, Rehab S Abdul-Maksoud2, Hala E Mowafy3, Walid S H Elsayed4.   

Abstract

Deregulated immunity is one of the most important factors implicated in recurrent pregnancy loss (RPL). The possible role of interleukin-33 (IL-33) and forkhead/winged helix transcription factor (Foxp3) in RPL have not been fully investigated. We aimed to evaluate IL-33 rs1929992 and Foxp3 rs2232365 single nucleotide polymorphisms (SNPs) and their serum levels in Egyptian RPL females. Blood samples were collected from 142 RPL patients and 123 women as healthy controls. IL-33 rs1929992 SNP was determined by polymerase chain reaction restriction fragment length polymorphism and Foxp3 rs2232365 SNP was determined using allele specific polymerase chain reaction. The serum IL-33 and Foxp3 levels were measured by enzyme linked immunosorbent assay. Foxp3 rs2232365 SNP showed statistically significant association with RPL. The risk of RPL was significantly higher in women carrying Foxp3 G allele than those carrying A allele. Lower serum levels of Foxp3 and IL-33 were observed in RPL patients than controls (P < 0.001). Foxp3 serum levels were much lower in carriers of G allele than those carrying A allele in all studied groups. Foxp3 rs2232365 SNP could be considered as a risk factor for RPL. The lowered serum levels of IL-33 and Foxp3 in RPL patients suggested that they might have an important role in the pathogenesis of the disease. Therefore, we hypothesized that Foxp3 polymorphisms may be important in RPL pathogenesis.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Foxp3, Polymorphism; Interleukin-33; PCR; Recurrent pregnancy loss

Mesh:

Substances:

Year:  2018        PMID: 29602154     DOI: 10.1016/j.cyto.2018.03.025

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  Dynamic Expression of Interleukin-33 and ST2 in the Mouse Reproductive Tract Is Influenced by Superovulation.

Authors:  Salma Begum; Barry E Perlman; Nuriban Valero-Pacheco; Valerie O'Besso; Tracy Wu; Sara S Morelli; Aimee M Beaulieu; Nataki C Douglas
Journal:  J Histochem Cytochem       Date:  2020-02-28       Impact factor: 2.479

2.  Maternal IL-33 critically regulates tissue remodeling and type 2 immune responses in the uterus during early pregnancy in mice.

Authors:  Nuriban Valero-Pacheco; Eric K Tang; Noura Massri; Rachel Loia; Anat Chemerinski; Tracy Wu; Salma Begum; Darine W El-Naccache; William C Gause; Ripla Arora; Nataki C Douglas; Aimee M Beaulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-22       Impact factor: 12.779

3.  Evaluation of Th17 and Treg cytokines in patients with unexplained recurrent pregnancy loss.

Authors:  Maral Farshchi; Elham Abdollahi; Nafiseh Saghafi; Ahmad Hosseini; Sara Fallahi; Sirus Rostami; Parifar Rostami; Houshang Rafatpanah; Mojtaba Habibagahi
Journal:  J Clin Transl Res       Date:  2022-05-25

4.  Development and utilization of human decidualization reporter cell line uncovers new modulators of female fertility.

Authors:  Meade Haller; Yan Yin; Liang Ma
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-09       Impact factor: 11.205

5.  Novel association between FOXO3 rs2232365 polymorphism and late-onset preeclampsia: a case-control candidate genetic study.

Authors:  Xuefeng Pan; Benjie Wei; Hong Wang; Lingyu Ma; Zhaoli Du; Ying Chen
Journal:  BMC Pregnancy Childbirth       Date:  2020-12-14       Impact factor: 3.007

Review 6.  Endometrial Immune Dysfunction in Recurrent Pregnancy Loss.

Authors:  Carlo Ticconi; Adalgisa Pietropolli; Nicoletta Di Simone; Emilio Piccione; Asgerally Fazleabas
Journal:  Int J Mol Sci       Date:  2019-10-26       Impact factor: 5.923

7.  Expression of IL-33 Receptor Is Significantly Up-Regulated in B Cells During Pregnancy and in the Acute Phase of Preterm Birth in Mice.

Authors:  Natalin Valeff; Lorena Juriol; Florencia Quadrana; Damián Oscar Muzzio; Marek Zygmunt; Maria Florencia Quiroga; María Silvia Ventimiglia; Federico Jensen
Journal:  Front Immunol       Date:  2020-03-27       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.